Using an unlevered Free Cash Flow to Firm (FCFF) model, we project Art's-Way Manufacturing Co., Inc.'s cash flows over 5 years with line-by-line expense modeling. Revenue is projected revenue growing from -1.2% to 2.2% annually, with expenses (COGS, SG&A, R&D) held at historical ratios. Depreciation is computed from a vintage matrix based on a 5-year useful life. Working capital is modeled using historical turnover days (DSO 41, DPO 32, DIO 209). At a 7.7% WACC with mid-year discounting, the terminal value (40% of enterprise value) is derived from the Gordon Growth Model on Year 6 FCFF at a 2.5% perpetual rate. After subtracting net debt, the equity value implies a fair price of $0.27 per share, suggesting ARTW is overvalued by 89.5% at the current price of $2.54.
Adjust parameters to explore scenarios. Changes are for exploration only and do not affect saved valuations.
| 2026 | 2027 | 2028 | 2029 | 2030 | Terminal | |
|---|---|---|---|---|---|---|
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| (−) Net Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| (+) D&A | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | 1 |
| (−) Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| (−) CapEx | 1 | 1 | 1 | 1 | 1 | 1 |
| (−) ΔWC | -3 | -0 | 0 | 0 | 0 | 0 |
| Free Cash Flow (FCFF) | 3 | 1 | 0 | 0 | 0 | 0 |
| Terminal Value | 4 | |||||
| WACC / Discount Rate | 7.7% | |||||
| Long-term Growth Rate | 2.5% | |||||
| Timing of FCF (mid year) | 0.5 | 1.5 | 2.5 | 3.5 | 4.5 | 5 |
| Present Value of FCF | 3 | 1 | 0 | 0 | 0 | 3 |
| Enterprise Value | 8 | |||||
| Projection Period | 5 | 60.4% | ||||
| Terminal Value | 3 | 39.6% | ||||
| (−) Current Net Debt | 6 | |||||
| Equity Value | 1 | |||||
| (/) Outstanding Shares | 5 | |||||
| Fair Price | $0.27 | |||||
| WACC \ Terminal Growth Rate | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.7% | $1 | $1 | $1 | $1 | $1 |
| 6.7% | $0 | $0 | $0 | $1 | $1 |
| 7.7% | $0 | $0 | $0 | $0 | $0 |
| 8.7% | $0 | $0 | $0 | $0 | $0 |
| 9.7% | $0 | $0 | $0 | $0 | $0 |
Current price: $2.54. Green = undervalued, Red = overvalued.
Using an unlevered Free Cash Flow to Firm (FCFF) model, we project Art's-Way Manufacturing Co., Inc.'s cash flows over 10 years with analyst estimates for the first 3–5 years, fading toward long-term GDP growth for the remaining years with line-by-line expense modeling. Revenue is projected revenue growing from -1.6% to 2.5% annually, with expenses (COGS, SG&A, R&D) held at historical ratios. Depreciation is computed from a vintage matrix based on a 5-year useful life. Working capital is modeled using historical turnover days (DSO 41, DPO 32, DIO 209). At a 7.7% WACC with mid-year discounting, the terminal value (24% of enterprise value) is derived from the Gordon Growth Model on Year 11 FCFF at a 2.5% perpetual rate. After subtracting net debt, the equity value implies a fair price of $0.32 per share, suggesting ARTW is overvalued by 87.5% at the current price of $2.54.
Adjust parameters to explore scenarios. Changes are for exploration only and do not affect saved valuations.
| 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | Terminal | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| (−) Net Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| (+) D&A | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| (−) Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| (−) CapEx | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| (−) ΔWC | -3 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow (FCFF) | 4 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terminal Value | 4 | ||||||||||
| WACC / Discount Rate | 7.7% | ||||||||||
| Long-term Growth Rate | 2.5% | ||||||||||
| Timing of FCF (mid year) | 0.5 | 1.5 | 2.5 | 3.5 | 4.5 | 5.5 | 6.5 | 7.5 | 8.5 | 9.5 | 5 |
| Present Value of FCF | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Enterprise Value | 8 | ||||||||||
| Projection Period | 6 | 76.0% | |||||||||
| Terminal Value | 2 | 24.0% | |||||||||
| (−) Current Net Debt | 6 | ||||||||||
| Equity Value | 2 | ||||||||||
| (/) Outstanding Shares | 5 | ||||||||||
| Fair Price | $0.32 | ||||||||||
| WACC \ Terminal Growth Rate | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.7% | $1 | $1 | $1 | $1 | $1 |
| 6.7% | $0 | $0 | $0 | $1 | $1 |
| 7.7% | $0 | $0 | $0 | $0 | $0 |
| 8.7% | $0 | $0 | $0 | $0 | $0 |
| 9.7% | $0 | $0 | $0 | $0 | $0 |
Current price: $2.54. Green = undervalued, Red = overvalued.
Using an unlevered Free Cash Flow to Firm (FCFF) model, we project Art's-Way Manufacturing Co., Inc.'s cash flows over 5 years with line-by-line expense modeling. Revenue is projected revenue growing from -1.2% to 2.2% annually, with expenses (COGS, SG&A, R&D) held at historical ratios. Depreciation is computed from a vintage matrix based on a 5-year useful life. Working capital is modeled using historical turnover days (DSO 41, DPO 32, DIO 209). At a 7.7% WACC with mid-year discounting, the terminal value (56% of enterprise value) is derived by applying the industry peer median EV/EBITDA multiple of 6.5x to Year 6 EBITDA. After subtracting net debt, the equity value implies a fair price of $0.85 per share, suggesting ARTW is overvalued by 66.7% at the current price of $2.54.
Adjust parameters to explore scenarios. Changes are for exploration only and do not affect saved valuations.
| 2026 | 2027 | 2028 | 2029 | 2030 | Terminal | |
|---|---|---|---|---|---|---|
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| (−) Net Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| (+) D&A | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | 1 |
| (−) Tax | 0 | 0 | 0 | 0 | 0 | — |
| (−) CapEx | 1 | 1 | 1 | 1 | 1 | — |
| (−) ΔWC | -3 | -0 | 0 | 0 | 0 | — |
| Free Cash Flow (FCF) | 3 | 1 | 0 | 0 | 0 | — |
| Peers' EBITDA Multiple | 6.5x | |||||
| Terminal Value | 9 | |||||
| WACC / Discount Rate | 7.72% | |||||
| Timing of FCF (mid year) | 0.5 | 1.5 | 2.5 | 3.5 | 4.5 | 5 |
| Present Value of FCF | 3 | 1 | 0 | 0 | 0 | 6 |
| Enterprise Value | 11 | |||||
| Projection Period | 5 | 43.7% | ||||
| Terminal Value | 6 | 56.3% | ||||
| (−) Current Net Debt | 6 | |||||
| Equity Value | 4 | |||||
| (÷) Outstanding Shares | 5M | |||||
| Fair Price | $1 | -66.7% | ||||
| WACC \ EV/EBITDA Exit Multiple | 2.5x | 4.5x | 6.5x | 8.5x | 10.5x |
|---|---|---|---|---|---|
| 5.7% | $0 | $1 | $1 | $1 | $2 |
| 6.7% | $0 | $1 | $1 | $1 | $2 |
| 7.7% | $0 | $0 | $1 | $1 | $2 |
| 8.7% | $0 | $0 | $1 | $1 | $1 |
| 9.7% | $0 | $0 | $1 | $1 | $1 |
Current price: $2.54. Green = undervalued, Red = overvalued.
Based on default parameters
Using an unlevered Free Cash Flow to Firm (FCFF) model, we project Art's-Way Manufacturing Co., Inc.'s cash flows over 10 years with analyst estimates for the first 3–5 years, fading toward long-term GDP growth for the remaining years with line-by-line expense modeling. Revenue is projected revenue growing from -1.6% to 2.5% annually, with expenses (COGS, SG&A, R&D) held at historical ratios. Depreciation is computed from a vintage matrix based on a 5-year useful life. Working capital is modeled using historical turnover days (DSO 41, DPO 32, DIO 209). At a 7.7% WACC with mid-year discounting, the terminal value (41% of enterprise value) is derived by applying the industry peer median EV/EBITDA multiple of 6.5x to Year 11 EBITDA. After subtracting net debt, the equity value implies a fair price of $0.78 per share, suggesting ARTW is overvalued by 69.1% at the current price of $2.54.
Adjust parameters to explore scenarios. Changes are for exploration only and do not affect saved valuations.
| 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | Terminal | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| (−) Net Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| (+) D&A | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| (−) Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| (−) CapEx | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | — |
| (−) ΔWC | -3 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Free Cash Flow (FCF) | 4 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Peers' EBITDA Multiple | 6.5x | ||||||||||
| Terminal Value | 9 | ||||||||||
| WACC / Discount Rate | 7.72% | ||||||||||
| Timing of FCF (mid year) | 0.5 | 1.5 | 2.5 | 3.5 | 4.5 | 5.5 | 6.5 | 7.5 | 8.5 | 9.5 | 5 |
| Present Value of FCF | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Enterprise Value | 10 | ||||||||||
| Projection Period | 6 | 58.7% | |||||||||
| Terminal Value | 4 | 41.3% | |||||||||
| (−) Current Net Debt | 6 | ||||||||||
| Equity Value | 4 | ||||||||||
| (÷) Outstanding Shares | 5M | ||||||||||
| Fair Price | $1 | -69.1% | |||||||||
| WACC \ EV/EBITDA Exit Multiple | 2.5x | 4.5x | 6.5x | 8.5x | 10.5x |
|---|---|---|---|---|---|
| 5.7% | $0 | $1 | $1 | $1 | $2 |
| 6.7% | $0 | $1 | $1 | $1 | $1 |
| 7.7% | $0 | $1 | $1 | $1 | $1 |
| 8.7% | $0 | $0 | $1 | $1 | $1 |
| 9.7% | $0 | $0 | $1 | $1 | $1 |
Current price: $2.54. Green = undervalued, Red = overvalued.
Based on default parameters
Using the industry peer median P/E Multiples multiple (trailing + forward), Art's-Way Manufacturing Co., Inc. (ARTW) has a fair value of $1.69 based on 1 comparable companies in the Agricultural - Machinery industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing P/E | Forward P/E | |
|---|---|---|---|
| Art's-Way Manufacturing Co., Inc.ARTW | 13 | 12.7x | — |
| Ten-League International Holdings Limited Ordinary Shares | 11 | 8.3x | — |
| Industry Median | 8.3x | — | |
| (*) Profit after tax | 1 | ||
| Equity Value | 9 | ||
| (/) Outstanding shares | 5 | ||
| Fair Price | $2 | ||
Using the industry peer median EV/EBITDA multiple (trailing + forward), Art's-Way Manufacturing Co., Inc. (ARTW) has a fair value of $0.13 based on 2 comparable companies in the Agricultural - Machinery industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing EV/EBITDA | Forward EV/EBITDA | |
|---|---|---|---|
| Art's-Way Manufacturing Co., Inc.ARTW | 13 | 17.9x | — |
| Ten-League International Holdings Limited Ordinary Shares | 11 | 6.0x | — |
| Cellyan Biotechnology Co., Ltd | 7 | 7.0x | — |
| Industry Median | 6.5x | — | |
| (*) EBITDA | 1 | ||
| = Enterprise Value | 7 | ||
| (-) Net Debt | 6 | ||
| Equity Value | 1 | ||
| (/) Outstanding shares | 5 | ||
| Fair Price | $0 | ||
Using the industry peer median EV/Revenue multiple (trailing + forward), Art's-Way Manufacturing Co., Inc. (ARTW) has a fair value of $0.62 based on 9 comparable companies in the Agricultural - Machinery industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing EV/Revenue | Forward EV/Revenue | |
|---|---|---|---|
| Art's-Way Manufacturing Co., Inc.ARTW | 13 | 0.8x | — |
| PS International Group Ltd. | 23 | 0.2x | — |
| Aqua Metals, Inc. | 16 | 117.1x | 2.3x |
| Ten-League International Holdings Limited Ordinary Shares | 11 | 0.9x | — |
| VerifyMe, Inc. | 10 | 0.4x | 0.3x |
| Cellyan Biotechnology Co., Ltd | 7 | 0.4x | — |
| Lakeside Holding Limited | 6 | 0.4x | — |
| Hydrofarm Holdings Group, Inc. | 5 | 1.2x | 0.8x |
| DirectBooking Technology Co., Ltd. | 4 | 0.4x | — |
| Li Bang International Corporation Inc. Ordinary Shares | 0 | 0.9x | — |
| Industry Median | 0.4x | 0.8x | |
| (*) Revenue | 23 | ||
| = Enterprise Value | 10 | ||
| (-) Net Debt | 6 | ||
| Equity Value | 3 | ||
| (/) Outstanding shares | 5 | ||
| Fair Price | $1 | ||
Using the PEG framework with historical EPS growth of 25.0%, the company has a fair value of $5.00 based on TTM EPS (FY2025) of $0.20. The current PEG ratio is 0.29.
PEG < 1 = bargain, 1–1.5 = fair, > 2 = expensive.
Growth above 25% is capped — hypergrowth may not be sustainable long-term.
| EPS Growth RateHistorical | 43.5% |
| Adjusted Growth (clamped 8–25%)Clamped | 25.0% |
| Fair P/E | 25.0x |
| TTM EPS (FY2025) | $0.20 |
| Fair Value | $5.00 |
No analyst estimates available.
| Year | Net Income | EPS | YoY |
|---|---|---|---|
| FY2021 | $212,631 | $0.05 | — |
| FY2022 | $97,797 | $0.02 | -55.8% |
| FY2023 | $266,969 | $0.05 | +156.7% |
| FY2024 | $307,375 | $0.06 | +13.9% |
| FY2025 | $1.0M | $0.20 | +228.9% |
4Y Historical EPS CAGR: 43.5%
Disclaimer: Sweet Value Lab provides estimated intrinsic values for informational purposes only. This is not financial advice. All models rely on assumptions that may not reflect future performance. Always do your own research before making investment decisions.